In contrast to most in vitro studies involving PBLs, we did not address the anti-tumor functions of NK and T cells individually but evaluated the interplay between CD4+ T cells, CD8+ T cells and NK cells on immune cell activation and tumor lysis upon delivery of IL-15/IL-15Rα and K2-Fc. The gene discussed is IL15; the disease is neoplasm.